|
Getting your Trinity Audio player ready...
|
By Naomi Kago
Nakuru-In Kenya’s health facilities, breast cancer is spoken of almost exclusively in the feminine. Every October brings pink ribbons, and public health campaigns urge women to examine themselves, get mammograms, and seek early detection. This messaging has saved many female lives. Over time, though, it has also built an invisible barrier for Kenyan men, who may believe, or feel culturally, that they are immune to the disease.
The result is a public health emergency unfolding in the shadows. Men step up to protect the women in their lives while quietly dying of a disease they do not think they can catch it.
In rural communities, health networks and advocates travel from village to village screening for reproductive cancers. Elizabeth Lagat, a consultant with the Cancer Community Consultant Linkage (C3 Link) in Nakuru, has spent years organising these missions, and she has noticed an irony in the role men play.
When a woman is flagged during a campaign and “marked” for clinical follow-up, C3 Link makes sure she stays on her treatment path. More often than not, the person driving that adherence is a man: a husband, brother, father, or son.
“Men play an incredibly noble role as caregivers in our missions,” Lagat says. “They are the ones who make sure that the marked female patients go for their checkups annually. They handle the heavy logistics, manage the financial strain, and physically escort their loved ones to regional referral facilities. They are absolute pillars in women’s treatment adherence.”
Yet that commitment stops at their own bodies. Men who diligently enforce the appointments of the women they protect almost never step into a facility for their own checkups.
“The crusade has historically favoured women,” Lagat says. “Because the messaging has been exclusively pink for decades, men don’t even stop to consider their own vulnerability. They see themselves solely as the protectors and providers, entirely detached from the risk.”
Stigma and misinformation make this worse. In many traditional communities, a man with a swelling in his breast risks ridicule, a perceived loss of masculinity, and isolation.
“Most men simply do not speak out for fear of stigma,” Lagat says. “They keep quiet, hide their symptoms, and suffer in absolute isolation because they do not have the proper information. They genuinely do not know that male biology includes breast tissue that can mutate into aggressive cancerous growths.”
To close this gap, C3 Link is changing its approach. Next year, for the first time since its founding, the organisation will run a dedicated campaign targeting both men and women. It aims to break down generational stigma, share locally relevant data, and challenge men in grassroots communities to learn their health status and commit to annual checkups.
“He thought it was pneumonia”
Because men do not examine their chests for abnormalities, they often misread the symptoms of male breast cancer (MBC) when they appear.
“Just recently, a male patient walked into the Nakuru Teaching and Referral Hospital [Nakuru Level 6 Hospital],” Lagat recalls. “He came in specifically seeking a checkup because he thought he was suffering from a severe, stubborn case of pneumonia. He had chest pains and breathing discomfort. When the medical team ran a full clinical examination, they discovered it wasn’t pneumonia at all. It was breast cancer.”
Part of the confusion is that when men think about cancers specific to their sex, one dominates their attention.
“The vast majority of men only take prostate cancer into consideration,” Lagat says. “Prostate cancer has received significant awareness as a male disease, so men are naturally more hyper-aware of it. Breast cancer doesn’t even register on their radar of possibilities.”
What the data shows
Dr. Peula Wanjiru Kingori, an oncologist at the Nakuru Teaching and Referral Hospital, set out to document the problem. Her study, titled “IMANI-KNH” (Insights into Male Breast Cancer Investigations at Kenyatta National Hospital), is a retrospective cohort analysis of the tumour features and survival of male breast cancer patients treated at Kenya’s leading referral hospital over several years.
The study examined a small group of confirmed cases. Most of the men were older, and the disease clustered among those in their sixties and seventies, though youth was no protection: a fifth of the patients were under fifty. They included farmers, security guards, small business owners and drivers, and nearly half had a history of smoking.
The most striking finding concerned how the disease presented. More than half of the men had no noticeable breast lump. Public campaigns teach a hard, distinct lump as the classic warning sign, so men without one had little reason to suspect cancer. Many sought care only when the disease had broken through the skin. More than a third presented with breast ulceration, meaning the tumour had grown outward into open, non-healing, infected sores on the chest wall.
The delay was long. The typical man waited a year and a half from the first symptoms to a hospital visit, and by the time of diagnosis, two in five already had Stage IV disease, meaning the cancer had spread to distant parts of the body.
CT scans, done for almost the entire group, showed how far it had travelled. The lungs were the most common site, which helps explain why men like Lagat’s patient mistake the disease for a respiratory illness. The cancer had also reached the bones, the lymph nodes under the arm and, in a few cases, the liver.
Under the microscope, the great majority of cases were invasive ductal carcinoma, an aggressive type that infiltrates surrounding tissue. Many tumours were moderately differentiated, while nearly a third were poorly differentiated, made up of fast-growing cells.
The survival figures show the cost of delay most clearly. Overall, most of the men were alive after one year and two years. Broken down by stage at diagnosis, the split was stark.
Every man diagnosed at Stage II or III was still alive at both one and two years. When the disease had not yet spread to distant organs, treatment (surgery such as mastectomy, chemotherapy, and chest wall radiation) preserved life.
For men who arrived at Stage IV, survival fell sharply: only about half were alive after one year, and fewer after two. Every death recorded in the study occurred among Stage IV patients.
Using multivariable Cox regression, Dr. Kingori identified the factors that most strongly shaped a man’s risk of dying. Arriving at Stage IV multiplied the risk of death many times over compared with earlier-stage disease, and distant metastasis raised the risk almost as steeply.
There was one piece of good news. Most patients had estrogen receptor-positive (ER+) tumours, which carried a much lower risk of death. These tumours respond to accessible hormone therapies such as tamoxifen, which nearly all the men on endocrine treatment received.
Age worked in a surprising direction. Patients aged fifty and above had a much lower risk of death than younger men, suggesting that breast cancer in younger Kenyan men may be more aggressive.
National Cancer Registry data adds geographic context. Breast cancer cases are concentrated in major healthcare hubs such as Nairobi and Nakuru counties, while remote areas like Wajir County record almost none, a pattern that likely reflects gaps in diagnosis. In referral centres like Nakuru Teaching and Referral Hospital, clinicians are well placed to catch these cases if men walk through the door.
The message of Dr. Kingori’s study is that male breast cancer is not a death sentence. The survival of every Stage II and III patient suggests Kenyan oncology services can treat men successfully. In this study, the deaths were concentrated among men who arrived late, after months of silence shaped by shame and a lack of public education.
Lagat’s call to action is a blueprint for the future of health advocacy in Kenya. Men have already proven themselves compassionate, dependable partners in the health of women in their communities. Now the public health system must help these same men step out of the caregiver’s shadow, shed the burden of stigma, and take charge of their own survival.
Kenyan men must take this message seriously, seek out accurate information and check their health regularly. Early detection does not only save a woman’s life. For a man, it may be the only thing that does.
